{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T07:28:35Z","timestamp":1725607715673},"publisher-location":"Boston, MA","reference-count":31,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781461365013"},{"type":"electronic","value":"9781461533986"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1992]]},"DOI":"10.1007\/978-1-4615-3398-6_33","type":"book-chapter","created":{"date-parts":[[2011,9,12]],"date-time":"2011-09-12T17:17:18Z","timestamp":1315847838000},"page":"305-316","source":"Crossref","is-referenced-by-count":6,"title":["Hormone Therapy of Prostatic Bone Metastases"],"prefix":"10.1007","author":[{"given":"Robert P.","family":"Huben","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"33_CR1","first-page":"293","volume":"1","author":"C Huggins","year":"1941","unstructured":"Huggins C. and Hodges C.V., Studies on prostatic cancer. 1. The effect of castration, estrogen and of androgen injections on serum phosphatases in metastatic carcinoma of the prostate, Recent Results Cancer Res. 1:293 (1941).","journal-title":"Recent Results Cancer Res."},{"key":"33_CR2","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0094-0143(21)00151-8","volume":"7","author":"GP Murphy","year":"1980","unstructured":"Murphy G.P. and Slack N.H., The questionable use of hormone therapy in advanced carcinoma of the prostate, Urol. Clin. N. Amer. 7:631\u2013638 (1980).","journal-title":"Urol. Clin. N. Amer."},{"key":"33_CR3","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1002\/cncr.1980.45.s7.1929","volume":"45","author":"WW Scott","year":"1980","unstructured":"Scott W.W., Menon M. and Walsh P.C., Hormonal therapy for prostatic cancer, Cancer 45:1929\u20131936 (1980).","journal-title":"Cancer"},{"key":"33_CR4","first-page":"175","volume-title":"Prostate Cancer","author":"M Menon","year":"1979","unstructured":"Menon M. and Walsh P.C., Hormonal therapy for prostatic cancer, in: \u201cProstate Cancer,\u201d pp. 175\u2013200, Murphy G.P. ed., PSG Pub. Co., MA. (1979)."},{"key":"33_CR5","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0022-5347(17)49115-4","volume":"133","author":"TJ Maatman","year":"1985","unstructured":"Maatman T.J., Gupta M.K. and Montie J.E., Effectiveness of castration versus intravenous estrogen therapy in producing rapid endocrine control of metastatic cancer of the prostate, J. Urol. 133:620\u2013621 (1985).","journal-title":"J. Urol."},{"key":"33_CR6","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1210\/endo-103-4-1096","volume":"103","author":"AJW Hsueh","year":"1978","unstructured":"Hsueh A.J.W., Dufau M.L. and Catt K.J., Direct inhibitory effect of estrogen on Leydig cell function of hypohysectomized rats, Endocrin. 103:1096\u20131102 (1978).","journal-title":"Endocrin"},{"key":"33_CR7","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/0090-4295(76)90301-0","volume":"7","author":"GR Prout","year":"1976","unstructured":"Prout G.R., Kliman B., Daly J.J., et al., Endocrine changes after diethylstilbestrol therapy. Effects on prostatic neoplasm and pituitary gonadal axis, Urol. 7:148\u2013155 (1976).","journal-title":"Urol."},{"key":"33_CR8","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1111\/j.1464-410X.1973.tb12238.x","volume":"45","author":"RJ Shearer","year":"1973","unstructured":"Shearer R.J., Hendry W.F., Sommerville I.F., et al., Plasma testosterone: An accurate monitor of hormone treatment in prostatic cancer, Brit. J. Urol. 45:668\u2013677 (1973).","journal-title":"Brit. J. Urol."},{"key":"33_CR9","first-page":"1011","volume":"124","author":"Veterans Administration Cooperative Urological Research Group","year":"1967","unstructured":"Veterans Administration Cooperative Urological Research Group, Treatment and survival of patients with cancer of the prostate, Surg. Gyn. Obs. 124:1011\u20131017 (1967).","journal-title":"Surg. Gyn. Obs."},{"key":"33_CR10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0022-5347(17)45620-5","volume":"135","author":"H Voogt De","year":"1986","unstructured":"De Voogt H., Smith P.H., Pavonel-Macaluso M., et al., Cardiovascular side effects of diethylstilbestrol, cyproterone acetate, medroxyprogesterone acetate and estramustine phosphate used for the treatment of advanced prostatic cancer: Results from European Organization for Research on Treatment of Cancer Trials 30761 and 30762, J. Urol. 135:303\u2013307 (1986).","journal-title":"J. Urol."},{"key":"33_CR11","doi-asserted-by":"crossref","first-page":"370","DOI":"10.7326\/0003-4819-97-3-370","volume":"97","author":"A Pont","year":"1982","unstructured":"Pont A., William P.L., Loose D.S., Feldman D., Reitz R.E., Bochra C. and Stevens D.A., Ketoconazole blocks adrenal steroid synthesis, Ann. Intern. Med. 97:370 (1982).","journal-title":"Ann. Intern. Med."},{"key":"33_CR12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0022-5347(17)49464-X","volume":"132","author":"J Trachtenberg","year":"1984","unstructured":"Trachtenberg J. Ketoconazole therapy in advanced prostatic cancer, J. Urol. 132:61 (1984).","journal-title":"J. Urol."},{"key":"33_CR13","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0022-5347(17)44290-X","volume":"137","author":"A Pont","year":"1987","unstructured":"Pont A., Long-term experience with high-dose ketoconazole therapy in patients with Stage D2 prostatic carcinoma, J. Urol. 137:902\u2013904 (1987).","journal-title":"J. Urol."},{"key":"33_CR14","doi-asserted-by":"crossref","unstructured":"Sanford E.J., Drago J.R., Rohner T.J., Jr., Santen R. and Lipton A., Aminoglutethimide medical adrenalectomy for advanced prostatic carcinoma, J. Urol. 115\u2013170 (1976).","DOI":"10.1016\/S0022-5347(17)59121-1"},{"key":"33_CR15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0022-5347(17)51916-3","volume":"129","author":"TJ Worgul","year":"1983","unstructured":"Worgul T.J., Santen R.J., Samojlik E., Veldhuis J.D., Lipton A., Harvey H.A., Dago J.R. and Rohner T.J., Clinical and biochemical effect of aminoglutethimide in the treatment of advanced prostatic carcinoma, J. Urol. 129:51 (1983).","journal-title":"J. Urol."},{"key":"33_CR16","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0022-5347(17)67001-0","volume":"114","author":"PC Walsh","year":"1975","unstructured":"Walsh P.C. and Siiteri P.K., Suppression of plasma androgens by spironolactone in castrated men with carcinoma of the prostate, J. Urol. 114:254\u2013256 (1975).","journal-title":"J. Urol."},{"key":"33_CR17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0022-5347(17)60352-5","volume":"109","author":"AJ Wein","year":"1973","unstructured":"Wein A.J. and Murphy J.J., Experience in the treatment of prostatic carcinoma with cyproterone acetate, J. Urol. 109:68 (1973).","journal-title":"J. Urol."},{"key":"33_CR18","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1464-410X.1980.tb02961.x","volume":"52","author":"GH Jacobi","year":"1980","unstructured":"Jacobi G.H., Altwein J.E., Kurth K.H., Basting R. and Hohenfellner R., Treatment of advanced prostatic cancer with parenteral cyproterone acetate: a Phase III randomized trial, Brit. J. Urol. 52:208 (1980).","journal-title":"Brit. J. Urol."},{"key":"33_CR19","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/0090-4295(78)90467-3","volume":"12","author":"J Geller","year":"1978","unstructured":"Geller J., Albert J. and Yen S.S.C., Treatment of advanced cancer of the prostate with megestrol acetate, Urology 12:537\u2013541 (1978).","journal-title":"Urology"},{"key":"33_CR20","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1210\/jcem-52-3-576","volume":"52","author":"J Geller","year":"1981","unstructured":"Geller J., Albert J., Yen S.S.C., et al., Medical castration of males with megestrol acetate and small doses of diethylstilbestrol, J. Clin. Endocrin. Metab. 52:576\u2013580 (1981).","journal-title":"J. Clin. Endocrin. Metab."},{"key":"33_CR21","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/1097-0142(1984)54:4<744::AID-CNCR2820540426>3.0.CO;2-P","volume":"54","author":"PC Sogani","year":"1984","unstructured":"Sogani P.C., Vagaiwala M.R. and Whitmore W.F., Jr., Experience with flutamide in patients with advanced prostatic cancer without prior endocrine therapy, Cancer 54:744\u2013750 (1984).","journal-title":"Cancer"},{"key":"33_CR22","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1056\/NEJM198908173210702","volume":"321","author":"ED Crawford","year":"1989","unstructured":"Crawford E.D., Eisenberger M.A., McLeod D., Spaulding J.T., Bensons R., Dorr F.A., Blumenstein B.A., Davis M.A. and Goodman P.J., Controlled trial of leuprolide with and without flutamide in prostatic carcinoma, New Engl. J. Med. 321:419\u2013424 (1989).","journal-title":"New Engl. J. Med."},{"key":"33_CR23","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/0006-291X(71)90766-2","volume":"43","author":"AV Schally","year":"1971","unstructured":"Schally A.V., Arimura A., Baba Y., Nair R.M.G., Matsuo H., Redding T.W., Debeljuk L. and White W.F. Isolation and properties of the FSH and LH releasing hormone, Biochem. Biophys. Res. Comm. 43:393 (1971).","journal-title":"Biochem. Biophys. Res. Comm."},{"key":"33_CR24","first-page":"119","volume":"20","author":"AV Schally","year":"1973","unstructured":"Schally A.V., Kastin A.J., Arimura A., et al., Basic and clinical studies with luteinizing hormone-releasing hormone (LH-RH) and its analogues, J. Reprod Fert. (Suppl.) 20:119\u2013136 (1973).","journal-title":"J. Reprod Fert."},{"key":"33_CR25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0022-5347(17)43870-5","volume":"137","author":"LM Glode","year":"1987","unstructured":"Glode L.M. and Smith J.A., Jr., Leuprolide Study Group: Long term suppression of LH, FSH and testosterone by daily administration of leuprolide, J. Urol. 137:57\u201360 (1987).","journal-title":"J. Urol."},{"key":"33_CR26","first-page":"69","volume":"303","author":"RAV Milsted","year":"1989","unstructured":"Milsted R.A.V., Initiation of-LHRH monotherapy for prostate cancer, Prog, in Clin. & Biol. Res. 303:69\u201374 (1989).","journal-title":"Prog, in Clin. & Biol. Res."},{"key":"33_CR27","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1056\/NEJM198411153112004","volume":"311","author":"The Leuprolide Study Group","year":"1984","unstructured":"The Leuprolide Study Group, Leuprolide versus diethylstilbestrol for metastatic prostate cancer, New Eng. J. Med. 311:1281\u20131286 (1984).","journal-title":"New Eng. J. Med."},{"key":"33_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0090-4295(89)90099-X","volume":"33","author":"WB Peeling","year":"1989","unstructured":"Peeling W.B., Phase III studies to compare goserelin (Zoladex) with orchiectomy and with diethylstilbestrol in treatment of prostatic carcinoma, Suppl. to Urol. 33:5\u201345 (1989).","journal-title":"Suppl. to Urol."},{"key":"33_CR29","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/pros.2990040605","volume":"4","author":"F Labrie","year":"1983","unstructured":"Labrie F., Dupont A., Belanger A., Lacoursiere Y., Raynaud J.P., Husson J.M., Gareau J., Fazekas A.T.A., Sandow J., Monfette G., Girard J.G., Emond J. and Houle J.G., New approach in the treatment of prostate cancer: Complete instead of partial withdrawal of androgens, The Prostate 4:579\u2013594 (1983).","journal-title":"The Prostate"},{"key":"33_CR30","first-page":"145","volume":"303","author":"G Lunglmayr","year":"1989","unstructured":"Lunglmayr G., On behalf of the International Prostate Cancer Study Group. \u201cZoladex\u201d versus \u201cZoladex\u201d plus flutamide in the treatment of advanced prostate cancer. First interim analysis of an international trial, Prog. in Clin.& Biol. Res. 303:145\u2013151 (1989).","journal-title":"Prog. in Clin.& Biol. Res."},{"key":"33_CR31","first-page":"129","volume":"303","author":"AP Carvalho","year":"1989","unstructured":"Carvalho A.P., de Moura C., Denis L., Newling D., Smith P.H., Bono A., Sylvester R., De Pauw M., Ongena P. and members of the EORTC Urological Group, Zoladex and flutamide vs. orchiectomy: A Phase III EORTC 30853 trial, Therap. Prog. in Urol. Cancers 303:129\u2013142 (1989).","journal-title":"Therap. Prog. in Urol. Cancers"}],"container-title":["Advances in Experimental Medicine and Biology","Prostate Cancer and Bone Metastasis"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4615-3398-6_33.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T12:22:46Z","timestamp":1638620566000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4615-3398-6_33"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992]]},"ISBN":["9781461365013","9781461533986"],"references-count":31,"URL":"https:\/\/doi.org\/10.1007\/978-1-4615-3398-6_33","relation":{},"ISSN":["0065-2598"],"issn-type":[{"type":"print","value":"0065-2598"}],"subject":[],"published":{"date-parts":[[1992]]}}}